Reprogramming the Dynamin 2 mRNA by Spliceosome-mediated RNA Trans-splicing
Dynamin 2 (DNM2) is a large GTPase, ubiquitously expressed, involved in membrane trafficking and regulation of actin and microtubule cytoskeletons. DNM2 mutations cause autosomal dominant centronuclear myopathy which is a rare congenital myopathy characterized by skeletal muscle weakness and histopa...
Saved in:
Main Authors: | Delphine Trochet (Author), Bernard Prudhon (Author), Arnaud Jollet (Author), Stéphanie Lorain (Author), Marc Bitoun (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spliceosome-Mediated Pre-mRNA trans-Splicing Can Repair CEP290 mRNA
by: Scott J. Dooley, et al.
Published: (2018) -
The Spliceosome Factor EFTUD2 Promotes IFN Anti-HBV Effect through mRNA Splicing
by: Pingping Hu, et al.
Published: (2023) -
Gene Therapy via Trans-Splicing for LMNA-Related Congenital Muscular Dystrophy
by: Feriel Azibani, et al.
Published: (2018) -
Development of versatile allele-specific siRNAs able to silence all the dominant dynamin 2 mutations
by: Swati Dudhal, et al.
Published: (2022) -
Repair of Mybpc3 mRNA by 5'-trans-splicing in a Mouse Model of Hypertrophic Cardiomyopathy
by: Giulia Mearini, et al.
Published: (2013)